NAFCILLIN SODIUM
Nafcillin for Injection, USP For Intramuscular or Intravenous Injection
Approved
Approval ID
090fda61-b9c8-640e-e063-6294a90a7363
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 1, 2023
Manufacturers
FDA
Armas Pharmaceuticals Inc.
DUNS: 098405973
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
NAFCILLIN SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72485-405
Application NumberANDA200002
Product Classification
M
Marketing Category
C73584
G
Generic Name
NAFCILLIN SODIUM
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateNovember 1, 2023
FDA Product Classification
INGREDIENTS (2)
NAFCILLIN SODIUMActive
Quantity: 1 g in 1 1
Code: 49G3001BCK
Classification: ACTIM
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
NAFCILLIN SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72485-406
Application NumberANDA200002
Product Classification
M
Marketing Category
C73584
G
Generic Name
NAFCILLIN SODIUM
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateNovember 1, 2023
FDA Product Classification
INGREDIENTS (2)
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
NAFCILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: 49G3001BCK
Classification: ACTIM